7 August 2024
Latham & Watkins Advises Seres Therapeutics in VOWST Asset Purchase Agreement With Nestlé Health Science
Advising firms
Deal team
30 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Scott Shean Lead | Latham & Watkins LLP | Partner | corporate | Not stated |
| Peter Handrinos Lead | Latham & Watkins LLP | Partner | corporate | Not stated |
| Gloria Ring | Latham & Watkins LLP | Counsel | corporate | Not stated |
| Jack Vanderford | Latham & Watkins LLP | Associate | corporate | Not stated |
| Jessica Mall | Latham & Watkins LLP | Associate | corporate | Not stated |
| Chris Hazuka | Latham & Watkins LLP | Partner | licensing and intellectual property | Not stated |
| Arun Mohan | Latham & Watkins LLP | Associate | licensing and intellectual property | Not stated |
| Mizuna Sekine | Latham & Watkins LLP | Associate | licensing and intellectual property | Not stated |
| Billy Wu | Latham & Watkins LLP | Associate | licensing and intellectual property | Not stated |
| Wesley Holmes | Latham & Watkins LLP | Partner | capital markets | Not stated |
| Lisa Martin | Latham & Watkins LLP | Partner | capital markets | Not stated |
| Jennifer Yoon | Latham & Watkins LLP | Partner | capital markets | Not stated |
| Andrew Rutsky | Latham & Watkins LLP | Associate | capital markets | Not stated |
| Haim Zaltzman | Latham & Watkins LLP | Partner | debt | Not stated |
| Dan Van Fleet | Latham & Watkins LLP | Partner | debt | Not stated |
| Hyunji Lee | Latham & Watkins LLP | Associate | debt | Not stated |
| Tyler Davis | Latham & Watkins LLP | Associate | debt | Not stated |
| Katharine Moir | Latham & Watkins LLP | Partner | tax | Not stated |
| William Kessler | Latham & Watkins LLP | Counsel | tax | Not stated |
| Matthew Conway | Latham & Watkins LLP | Partner | employment and benefits | Not stated |
| Bryce Williamson | Latham & Watkins LLP | Associate | employment and benefits | Not stated |
| Britton Davis | Latham & Watkins LLP | Counsel | antitrust | Not stated |
| Dennis Craythorn | Latham & Watkins LLP | Partner | public company representation | Not stated |
| Jamie Conn | Latham & Watkins LLP | Associate | public company representation | Not stated |
| Ben Haas | Latham & Watkins LLP | Partner | FDA regulatory | Not stated |
| Betty Pang | Latham & Watkins LLP | Partner | FDA regulatory | Not stated |
| Chad Jennings | Latham & Watkins LLP | Counsel | FDA regulatory | Not stated |
| Jeanne Fabre | Latham & Watkins LLP | Associate | FDA regulatory | Not stated |
| Heather Deixler | Latham & Watkins LLP | Partner | data privacy | Not stated |
| Mitch Bennett | Latham & Watkins LLP | Associate | data privacy | Not stated |
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- Seres Therapeutics, Inc.Sell-side
- Counterparties
- Nestlé Health Science (Buy-side)